Cedara Software (Mississauga, Ontario) has agreed to supply Instrumentarium Imaging (Helsinki, Finland) with a customized version of its Cedara I-Acquire/MG digital acquisition software. The software will be used in Instrumentarium's Diamond full-field
Cedara Software (Mississauga, Ontario) has agreed to supply Instrumentarium Imaging (Helsinki, Finland) with a customized version of its Cedara I-Acquire/MG digital acquisition software. The software will be used in Instrumentarium's Diamond full-field digital mammography system. According to the Dec. 19 announcement, I-Acquire will integrate the flat-panel digital detector, controller, and x-ray generator. I-Acquire will also provide automated workflow, image display manipulation, DICOM communication, and information system integration. Its open architecture will allow the future integration of clinical applications and advanced image processing algorithms, according to Cedara.
The company's I-Acquire software will be integrated into a digital radiography product being manufactured in China. I-Acquire will be supplied to Beijing WanDong Medical Equipment, one of China's largest x-ray equipment manufacturers, as part of a deal announced Dec. 13. The transaction with WanDong also includes Cedara's I-SoftView diagnostic workstation. Cedara designed the software to interface with multiple x-ray acquisition devices, including digital flat-panel detectors as well as computed radiography scanners and readers. I-Acquire features multiple control support, patient demographics, procedure input, intuitive image manipulation tools, and image enhancement algorithms that automatically optimize clinical images, quickening patient throughput.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.